Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

fludarabine 5Cyclophosphamide 5Cyclosporine 4fludarabine phosphate 3Whole-Body Irradiation 3Imatinib Mesylate 3Therapeutics 2Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Methotrexate 2Hematologic Tests 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1nilotinib 1bosutinib 1Urinalysis 1Transplantation, Homologous 1Tetanus Toxoid 1Standard of Care 1Resistance Training 1Registries 1Radiotherapy 1Pharmaceutical Services 1Ondansetron 1Nurse Clinicians 1Modafinil 1Melphalan 1Health Promotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Nurse Clinicians × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡